GRASSILLI EMANUELA

Ruolo: 
Tecnologo
Telefono: 
0264488050
Stanza: 
U8, Piano: IV, Stanza: 4008
Via Cadore, 48 - 20900 MONZA

Pubblicazioni

  • Lavitrano, M., Ianzano, L., Bonomo, S., Cialdella, A., Cerrito, M., Pisano, F., et al. (2020). BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers. JOURNAL OF PATHOLOGY, 250(2), 134-147 [10.1002/path.5347]. Dettaglio
  • Scagliotti, A., Grassilli, E., Cazzaniga, M., Capizzi, L., Lavitrano, M., & Cerrito, M. (2020). The antiangiogenic effect of the metronomic combination of 5-Fluorouracil plus vinorelbine is mediated by FAK/AKT pathway downregulation and apoptosis activation. EUROPEAN JOURNAL OF CANCER, 138(suppl 2), S26-S26 [10.1016/S0959-8049(20)31134-5]. Dettaglio
  • Basile, D., Gerratana, L., Buonadonna, A., Garattini, S., Perin, T., Grassilli, E., et al. (2019). Role of Bruton's Tyrosine Kinase in Stage III Colorectal Cancer. CANCERS, 11(6) [10.3390/cancers11060880]. Dettaglio
  • Giordano, F., Vaira, V., Cortinovis, D., Bonomo, S., Goedmakers, J., Brena, F., et al. (2019). p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 38(1) [10.1186/s13046-019-1199-7]. Dettaglio
  • Sala, L., Cirillo, G., Riva, G., Romano, G., Giussani, C., Cialdella, A., et al. (2019). Specific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic Histotype. FRONTIERS IN MOLECULAR NEUROSCIENCE, 12 [10.3389/fnmol.2019.00002]. Dettaglio